We are pleased to share Wellnex Life (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently released a key ASX announcement.
Wellnex Life Limited (ASX: WNX) (“Wellnex” or “the Company”) announces changes to the board and to management post the successful dual listing on the AIM Market of the London Stock Exchange (“AIM”).
Announcement Highlights
Having guided the Company through a transformational period and the successful AIM IPO, NonExecutive Chairman, Mr George Tambassis, has tendered his resignation to the board due to recent increased external work commitments that will not allow him to dedicate the required time to Wellnex Life as a public company.
Mr Tambassis has played a pivotal role for the Company and leaves Wellnex in a much stronger position, with the extinguishment of circa A$13 million in debt following the AIM IPO.
Whilst the Company commences its search for a new Chairman, Mr Andrew Vidler, current independent Non-Executive Director, has agreed on an interim basis to assume the non-executive Chairman role, effective immediately. The interim appointment of Mr Vidler will allow for a seamless transition of the Chair role. Mr Tambassis will remain available to the Company should his advice or guidance be required.
The board would like to thank Mr Tambassis for his valuable contribution and Mr Andrew Vidler for agreeing to take up the role as interim Non-Executive Chairman.
With the dual listing of Wellnex Life on the AIM market and the continued growth of the business domestically and internationally across brands and IP licensing, the board is pleased to announce that Mr Zack Bozinovski, joint Managing Director, has been appointed as joint CEO. This appointment will ensure a dedicated focus to continuing business growth and increasing shareholder value.
Read the full Wellnex Life ASX announcement here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
